Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify evidence-based guidelines for treating major
depressive disorder to full remission in Taiwanese major depressive disorder (MDD) patients.
To achieve this goal, the investigators aim to: (1) evaluate the risks and benefits of
adjunctive pharmacotherapies for cognitive and metabolic consequences in MDD, and (2) clarify
the shared biological mechanisms between mood, immune and metabolism homeostasis